search
Back to results

Effectiveness of a Guided Mobile App Intervention for Depression and Anxiety in University Students (PROMES-U Study) (PROMES-U)

Primary Purpose

Depressive Symptoms, Anxiety

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
MyMoodCoach
Sponsored by
University of the Balearic Islands
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Depressive Symptoms

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Eligible participants are all undergraduate students at the 6 participating universities and students followed in the PROMES-U observational study Having 18 years of age or more Having literacy in Spanish Having access to a smartphone (Android or Apple) With mild or moderate depression and/or anxiety symptoms screened (i.e., depression (5≤ (PHQ-9) ≤14); and/or anxiety (5≤ GAD-7 ≤14). Exclusion Criteria: Moderately severe or severe depression and/or anxiety (i.e., PHQ-9≥15 and/or GAD-7≥15) High suicide risk A history of severe psychiatric disorder (e.g., bipolar, psychosis) Being on mental health treatment (i.e., medication, psychotherapy or other intervention) Students with high suicide risk will receive a clinical alert recommending them to visit a specialist and a list of available mental health resources.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    No Intervention

    Arm Label

    MyMoodCoach Intervention

    Treatment-as-usual monitoring control group

    Arm Description

    Outcomes

    Primary Outcome Measures

    Change of depressive symptoms
    The primary outcome will be the change of depressive symptoms at post-intervention (up to 6 weeks), 6 months and 12 months post randomization, considering the minimal clinically relevant change in the scores of Patient Health Questionnaire-9 (PHQ-9) and the Patient Health Questionnaire Anxiety and Depression Scale (PHQ-ADS). The PHQ-9 range from 0 to 27, higher scores mean a worse outcome. The PHQ-ADS range from 0 to 48 with higher scores indicating more severe depression.
    Change of anxiety symptoms
    The primary outcome will be the change of anxiety symptoms at post-intervention (up to 6 weeks), 6 months and 12 months post randomization, considering the minimal clinically relevant change in the scores of Generalized Anxiety Disorder -7 (GAD-7) he Patient Health Questionnaire Anxiety and Depression Scale (PHQ-ADS). The GAD-7 range from 0 to 21, higher scores mean a worse outcome. The PHQ-ADS range from 0 to 48 with higher scores indicating more severe anxiety.

    Secondary Outcome Measures

    Full Information

    First Posted
    September 28, 2023
    Last Updated
    October 5, 2023
    Sponsor
    University of the Balearic Islands
    Collaborators
    Hospital del Mar Research Institute (IMIM), Universitat Jaume I, Universidad Miguel Hernandez de Elche, Universitat Pompeu Fabra, Universidad de Zaragoza, University of Malaga, Instituto de Salud Carlos III
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT06078007
    Brief Title
    Effectiveness of a Guided Mobile App Intervention for Depression and Anxiety in University Students (PROMES-U Study)
    Acronym
    PROMES-U
    Official Title
    Effectiveness of a Guided Mobile App Intervention for Depression and Anxiety in University Students: a Multicenter Randomized Controlled Trial (PROMES-U Study)
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    October 2023
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    October 2023 (Anticipated)
    Primary Completion Date
    April 2024 (Anticipated)
    Study Completion Date
    April 2024 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    University of the Balearic Islands
    Collaborators
    Hospital del Mar Research Institute (IMIM), Universitat Jaume I, Universidad Miguel Hernandez de Elche, Universitat Pompeu Fabra, Universidad de Zaragoza, University of Malaga, Instituto de Salud Carlos III

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No

    5. Study Description

    Brief Summary
    Background: Symptoms of depression and anxiety are prevalent among Spanish university students. Minimally guided online interventions have shown promise in reducing symptomatology and preventing increased mental distress. There is a need to evaluate the effectiveness of guided preventive mental health interventions for depression and anxiety in university students. Methods: two-arm multicenter randomized controlled trial (RCT), addressed to undergraduate students from 6 public universities with symptoms of depression and/or anxiety. Students will be evaluated through an online survey assessing mental health problems, use of mental health services, sociodemographic variables, self-perceived health, childhood and adolescent adversities, recent stressful events, social networks, personality and university experiences. A total of 600 students will be randomly assigned to: intervention group (guided E-health prevention intervention) or control group (treatment as usual with self-monitoring). The intervention, in app format, is based on principles of cognitive behavioral therapy, includes weekly feedback based on content and participation from a psychologist and self-monitoring. Assessments will take place post-intervention (up to 6 weeks), at 6 months and 12 months after randomization. The primary outcome will be the reduction of depressive or anxiety symptoms post-intervention, assessed with the Patient Health Questionnaire-9 (PHQ-9), the Generalized Anxiety Disorder-7 (GAD-7) and the Patient Health Questionnaire-Anxiety and Depression Scale (PHQ-ADS). Secondary outcomes of the RCT will be mental wellbeing, academic stress, comorbid symptoms, and adherence. Analyses will be conducted on an intention-to-treat and per protocol basis. Discussion: The results of the PROMES-U RCT will provide valuable information on a guided preventive online intervention that could be delivered in the campus context. In addition, results will provide information on the positive impact of the intervention on other relevant factors involved in mental health among university students.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Depressive Symptoms, Anxiety

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    600 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    MyMoodCoach Intervention
    Arm Type
    Experimental
    Arm Title
    Treatment-as-usual monitoring control group
    Arm Type
    No Intervention
    Intervention Type
    Behavioral
    Intervention Name(s)
    MyMoodCoach
    Intervention Description
    The MyMoodCoach prevention intervention is an evidence-based online intervention based on cognitive-behavioral therapy principles such as behavioral activation, problem solving and challenging negative thoughts.
    Primary Outcome Measure Information:
    Title
    Change of depressive symptoms
    Description
    The primary outcome will be the change of depressive symptoms at post-intervention (up to 6 weeks), 6 months and 12 months post randomization, considering the minimal clinically relevant change in the scores of Patient Health Questionnaire-9 (PHQ-9) and the Patient Health Questionnaire Anxiety and Depression Scale (PHQ-ADS). The PHQ-9 range from 0 to 27, higher scores mean a worse outcome. The PHQ-ADS range from 0 to 48 with higher scores indicating more severe depression.
    Time Frame
    Up to 6 weeks, at 6 months and 12 months after randomization
    Title
    Change of anxiety symptoms
    Description
    The primary outcome will be the change of anxiety symptoms at post-intervention (up to 6 weeks), 6 months and 12 months post randomization, considering the minimal clinically relevant change in the scores of Generalized Anxiety Disorder -7 (GAD-7) he Patient Health Questionnaire Anxiety and Depression Scale (PHQ-ADS). The GAD-7 range from 0 to 21, higher scores mean a worse outcome. The PHQ-ADS range from 0 to 48 with higher scores indicating more severe anxiety.
    Time Frame
    Up to 6 weeks and at 6 months and 12 months post randomization

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Eligible participants are all undergraduate students at the 6 participating universities and students followed in the PROMES-U observational study Having 18 years of age or more Having literacy in Spanish Having access to a smartphone (Android or Apple) With mild or moderate depression and/or anxiety symptoms screened (i.e., depression (5≤ (PHQ-9) ≤14); and/or anxiety (5≤ GAD-7 ≤14). Exclusion Criteria: Moderately severe or severe depression and/or anxiety (i.e., PHQ-9≥15 and/or GAD-7≥15) High suicide risk A history of severe psychiatric disorder (e.g., bipolar, psychosis) Being on mental health treatment (i.e., medication, psychotherapy or other intervention) Students with high suicide risk will receive a clinical alert recommending them to visit a specialist and a list of available mental health resources.
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Jordi Alonso
    Phone
    93 316 07 60
    Email
    jalonso@imim.es
    First Name & Middle Initial & Last Name or Official Title & Degree
    PROMES-U Study
    Email
    promes@imim.es
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Jordi Alonso
    Organizational Affiliation
    Hospital de Mar Medical Research Institute (IMIM)
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    No

    Learn more about this trial

    Effectiveness of a Guided Mobile App Intervention for Depression and Anxiety in University Students (PROMES-U Study)

    We'll reach out to this number within 24 hrs